Volume | 249,774 |
|
|||||
News | (1) | ||||||
Day High | 1.75 | Low High |
|||||
Day Low | 1.53 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Helius Medical Technologies Inc | HSDT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.63 | 1.53 | 1.75 | 1.63 | 1.70 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,450 | 249,774 | $ 1.61 | $ 402,145 | - | 1.53 - 14.44 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:29:15 | formt | 113 | $ 1.60 | USD |
Helius Medical Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.13M | 708.25k | - | 644k | -8.85M | -12.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Helius Medical Technolog... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSDT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.59 | 3.61 | 1.53 | 2.63 | 3,341,147 | -1.96 | -54.60% |
1 Month | 6.00 | 6.17 | 1.53 | 2.66 | 856,175 | -4.37 | -72.83% |
3 Months | 6.49 | 7.188 | 1.53 | 4.26 | 560,035 | -4.86 | -74.88% |
6 Months | 6.66 | 9.50 | 1.53 | 4.80 | 345,624 | -5.03 | -75.53% |
1 Year | 8.84 | 14.44 | 1.53 | 7.37 | 420,912 | -7.21 | -81.56% |
3 Years | 774.00 | 863.00 | 1.53 | 37.90 | 712,343 | -772.37 | -99.79% |
5 Years | 4,112.50 | 5,792.50 | 1.53 | 321.51 | 571,721 | -4,110.87 | -99.96% |
Helius Medical Technolog... Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. |